Feasibility and Procedural Considerations of Balloon‐Expandable TAVR in Patients With Prior Endovascular Aortic Stent Grafts
Catheterization and Cardiovascular Interventions · 2026
DOI: 10.1002/ccd.70867 ↗Kurz gefasst
Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, 2026. Verfasst von Iad Alhallak und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Disease, McGovern Medical School at UTHealth Houston, Houston, Texas, USA. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Stents, Transcatheter Aortic Valve Replacement, Blood Vessel Prosthesis. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objectives
To evaluate the feasibility and short‐term outcomes of transcatheter aortic valve replacement (TAVR) using balloon‐expandable Sapien valves in patients with prior endovascular aortic stent grafts.
Methods
We conducted a single‐center, retrospective study of 23 patients with prior endovascular aortic stent grafts who underwent TAVR between 2012 and 2025 using Sapien platform balloon‐expandable valves. Descriptive statistics and univariate logistic regression analysis were used to characterize and identify outcomes of peri‐procedural complications.
Results
Transfemoral access was used in 87% of cases, and valve deployment was successful in all patients without aortic injuries or graft‐related complications during the procedural and up to 30‐day post‐procedure period. Median length of stay was 3 days, and there were no deaths up to 30‐days. Post‐procedural events were infrequent and included new‐onset atrial fibrillation ( n = 2), transient hemodialysis ( n = 1), pleural effusion ( n = 1), and stroke ( n = 1). In exploratory analyses limited by the small number of events, older age (OR 1.27, 95% CI 1.04–1.71) and higher baseline mean aortic‐valve gradient (OR 1.24, 95% CI 1.06–1.76) were associated with periprocedural events.
Conclusions
The complications observed in our cohort are general outcomes associated with TAVR, instead of graft‐associated outcomes. Balloon‐expandable TAVR is technically safe and feasible in patients with prior endovascular aortic stent grafts when performed at experienced centers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Disease, McGovern Medical School at UTHealth Houston, Houston, Texas, USA.
- Department of Cardiothoracic and Vascular Surgery, McGovern Medical School at UTHealth Houston, Houston, Texas, USA.
ORCID-Profile: Iad Alhallak, Ken Chan, Biswajit Kar, Richard Smalling
Zitieren
APA
Alhallak, I., Mills, A., Bequeaith, B., Chan, K., Tanaka, A., Estrera, A. L., Kar, B., Smalling, R., & Dhoble, A. (2026). Feasibility and Procedural Considerations of Balloon‐Expandable TAVR in Patients With Prior Endovascular Aortic Stent Grafts. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70867
Vancouver
Alhallak I, Mills A, Bequeaith B, Chan K, Tanaka A, Estrera AL, et al. Feasibility and Procedural Considerations of Balloon‐Expandable TAVR in Patients With Prior Endovascular Aortic Stent Grafts. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70867
BibTeX
@article{Alhallak2026,
author = {Alhallak, Iad and Mills, Alexander and Bequeaith, Beau and Chan, Ken and Tanaka, Akiko and Estrera, Anthony L and Kar, Biswajit and Smalling, Richard and Dhoble, Abhijeet},
title = {Feasibility and Procedural Considerations of Balloon‐Expandable TAVR in Patients With Prior Endovascular Aortic Stent Grafts},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
doi = {10.1002/ccd.70867}
}
EUVIMED